Table 2.
Means (SD's) of TACQOL scores at 6 weeks and at 1 year by diagnostic groups
| Norms | All (n = 52) | Leukemia (n = 17) | Lymphoma (n = 19) | Brain tumors (n = 7) | Other solid tumors (n = 9) | pk | |
| TACQOL T1 | |||||||
| Physical functions | 25.3** (5.0) | 23.2 (5.3) | 20.3 (5.7) | 24.4 (4.2) | 26.9 (5.0) | 22.8 (4.7) | .03 |
| Motor functions | 14.8*** (2.0) | 11.3 (4.3) | 8.8 (4.9) | 12.3 (4.1) | 13.1 (2.9) | 12.3 (2.7) | .06 |
| Autonomy | 15.8*** (0.9) | 15.0 (1.5) | 14.7 (1.8) | 15.4 (1.0) | 14.7 (1.1) | 14.8 (2.1) | .51 |
| Cognitive functions | 13.8 (2.6) | 14.4 (2.6) | 13.6 (3.8) | 14.8 (1.5) | 15.2 (1.3) | 14.3 (2.1) | .70 |
| Social functions | 14.4 (1.9) | 14.4 (2.2) | 13.1 (3.3) | 14.8 (1.3) | 15.3 (0.5) | 15.0 (1.0) | .35 |
| Positive emotions | 7.2*** (1.3) | 5.9 (1.9) | 5.6 (1.7) | 5.8 (2.2) | 6.0 (2.0) | 6.3 (1.7) | .78 |
| Negative emotions | 5.6 (1.5) | 5.8 (1.7) | 5.8 (2.2) | 6.0 (1.4) | 6.4 (1.3) | 4.7 (1.2) | .09 |
| TACQOL T2 | |||||||
| Physical functions | 25.3*** (5.0) | 27.4††† (3.8) | 27.1†† (3.7) | 28.0†† (3.1) | 24.3 (4.6) | 29.1† (3.8) | .08 |
| Motor functions | 14.8** (2.0) | 13.2† (3.6) | 13.1† (4.1) | 14.4 (1.9) | 12.3 (3.5) | 11.3 (5.1) | .20 |
| Autonomy | 15.8 (0.9) | 15.7†† (1.0) | 15.4 (1.5) | 16.0† (0.0) | 15.4 (1.5) | 16.0 (0.0) | .17 |
| Cognitive functions | 13.8 (2.6) | 13.6 (2.5) | 13.6 (2.8) | 13.5 (2.7) | 13.9 (2.5) | 13.8 (1.9) | .99 |
| Social functions | 14.4 (1.9) | 14.7 (1.5) | 14.7† (1.8) | 14.8 (1.3) | 14.0 (1.5) | 14.8 (1.3) | .55 |
| Positive emotions | 7.2** (1.3) | 6.6† (1.5) | 6.8† (1.6) | 6.8 (1.4) | 5.4 (1.4) | 6.7 (1.5) | .20 |
| Negative emotions | 5.6 (1.5) | 5.5 (1.6) | 5.7 (1.8) | 5.8 (1.6) | 5.0† (2.1) | 4.9 (0.8) | .57 |
Note: Significant differences between sample und healthy reference group: ** p < .01; *** p < .001; Significant differences between T1 and T2: † p < .05; †† p < .01; ††† p < .001; k Kruskal-Wallis tests, multiple group comparisons